Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-55,200
Closed -$905K 5328
2025
Q4
$905K Buy
+55,200
New +$859K ﹤0.01% 3503
2024
Q3
Sell
-300,000
Closed -$3.8M 5428
2024
Q2
$3.8M Sell
300,000
-465,000
-61% -$8.04M ﹤0.01% 1704
2024
Q1
$17.3M Buy
765,000
+575,000
+303% +$13.5M 0.01% 1066
2023
Q4
$4.72M Buy
+190,000
New +$3.71M ﹤0.01% 2147
2023
Q2
Sell
-256,700
Closed -$4.51M 4951
2023
Q1
$4.51M Buy
+256,700
New +$3.88M ﹤0.01% 1616
2022
Q2
Sell
-701,200
Closed -$15.1M 5197
2022
Q1
$15.1M Buy
+701,200
New +$23.6M 0.01% 777

Other funds holding PATH

Barclays's PATH Position: Q2 2026 in Review

Barclays increased its UiPath (PATH) stake by 147% in Q2 2026, buying an estimated $6.45M and bringing the position to 1,015,286 shares worth $11M. The position accounts for ﹤0.01% of the portfolio, ranked #1431.

Barclays first reported a position in PATH in Q1 2022 and has held it in 18 quarters since. The position peaked at $25.8M in Q4 2025. 529 funds tracked by Wall St. Rank hold PATH as of Q2 2026.

  • Barclays held 1,015,286 shares of UiPath worth $11M as of Q2 2026.
  • Barclays bought 604,182 UiPath shares in Q2 2026, an estimated $6.45M.
  • UiPath made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1431 holding.
  • Barclays first reported a position in UiPath in Q1 2022 and has held it in 18 quarters since.
  • Barclays's UiPath position peaked at $25.8M in Q4 2025.
  • 529 funds tracked by Wall St. Rank held UiPath as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.